ASHKEN IAN G H 4
4 · APi Group Corp · Filed May 6, 2026
Research Summary
AI-generated summary of this filing
APi Group (APG) Director Ian G.H. Ashken Sells 1,084,000 Shares
What Happened Ian G.H. Ashken, a director of APi Group Corp (APG), disposed of a total of 1,084,000 shares across transactions on May 4–5, 2026, yielding roughly $48,536,904. Transaction breakdown reported in the Form 4:
- May 4, 2026 — 134,265 shares at $44.70 — $6,001,646
- May 4, 2026 — 34,201 shares at $45.34 — $1,550,673
- May 4, 2026 — 850,000 shares at $44.71 — $38,003,500 (contributed to an exchange fund per footnote)
- May 5, 2026 — 50,634 shares at $45.38 — $2,297,771
- May 5, 2026 — 14,900 shares at $45.86 — $683,314
These were sales (S). The largest tranche (850,000 shares) was contributed to an exchange fund (valued at $44.71/share for that purpose) rather than a traditional open‑market sale.
Key Details
- Transaction dates: May 4–5, 2026; Form 4 filed May 6, 2026 (timely filing).
- Total shares sold: 1,084,000; total proceeds: ~$48,536,904.
- Price ranges (per filing footnotes): sales on May 4 ranged roughly $44.19–$45.74 across tranches; May 5 sales ranged roughly $44.78–$46.00 (see footnotes F2–F7 for per-tranche ranges and weighted averages).
- Sales effected pursuant to a Rule 10b5-1 trading plan adopted May 7, 2025 (footnote F1).
- Holdings/beneficial ownership: shares are held through trusts and entities (Nancy and Ian Ashken Investment Trust LLLP, Mariposa Acquisition IV, LLC). Mr. Ashken disclaims beneficial ownership except to the extent of his pecuniary interest. The filing notes a pecuniary interest in 15,552 common shares and 1,152,000 Series A preferred shares held by Mariposa (footnote F11). The filing excerpt provided does not state the full number of shares owned after these transactions.
- Nature of disposition: included an exchange‑fund contribution (footnote F5) in addition to open‑market/private sales.
Context
- These sales were made under a pre‑arranged 10b5‑1 plan, which typically schedules trades in advance and can indicate routine disposition rather than opportunistic trades on nonpublic information. That reduces — but does not eliminate — the usual interpretive value of insider sales.
- Sales do not necessarily signal negative company prospects; purchases are generally more informative about insider confidence. The filing includes customary trust/beneficial ownership disclaimers, so reported holdings reflect pecuniary interests through related entities rather than direct personal ownership.
Insider Transaction Report
Form 4
ASHKEN IAN G H
Director
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-05-04$44.70/sh−134,265$6,001,646→ 10,427,019 total(indirect: By Trust) - Sale
Common Stock
[F1][F4][F3]2026-05-04$45.34/sh−34,201$1,550,673→ 10,392,818 total(indirect: By Trust) - Sale
Common Stock
[F5][F3]2026-05-04$44.71/sh−850,000$38,003,500→ 9,542,818 total(indirect: By Trust) - Sale
Common Stock
[F1][F6][F3]2026-05-05$45.38/sh−50,634$2,297,771→ 9,492,184 total(indirect: By Trust) - Sale
Common Stock
[F1][F7][F8]2026-05-05$45.86/sh−14,900$683,314→ 9,477,284 total(indirect: By Trust)
Holdings
- 300,000(indirect: See footnote)
Common Stock
[F9] - 53,730(indirect: By Trust)
Common Stock
[F10] - 15,552(indirect: By LLC)
Common Stock
[F11] - 4,740
Restricted Stock Units
[F12][F13]→ Common Stock (4,740 underlying) - 1,152,000(indirect: By LLC)
Series A Preferred Stock
[F14][F11]→ Common Stock (1,152,000 underlying)
Footnotes (14)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Nancy and Ian Ashken Investment Trust LLLP (the "Investment Trust") on May 7, 2025.
- [F10]The shares of Common Stock reported herein are held directly by the Ashken Trust, of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
- [F11]The shares of Common Stock and Series A Preferred Stock are held directly by Mariposa Acquisition IV, LLC. The Nancy and Ian Ashken Investment Trust LLLP (the "Ashken Investment Trust"), the general partner of which is wholly-owned by The Ian G.H. Ashken Living Trust (the "Ashken Trust"), of which Mr. Ashken is the trustee and beneficiary, holds a limited liability company interest in Mariposa Acquisition IV, LLC and, as a result, may be deemed to have a pecuniary interest in 15,552 shares of Common Stock and 1,152,000 shares of Series A Preferred Stock held by Mariposa Acquisition IV, LLC. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
- [F12]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
- [F13]These restricted stock units vest on May 16, 2026, which is the one-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.
- [F14]The Series A Preferred Stock is convertible at any time at the election of the holder, on a one-for-one basis, into shares of Common Stock for no additional consideration. The Series A Preferred Stock shall automatically convert into Common Stock on the last day of the seventh full financial year of the Issuer following October 1, 2019 (or if such date is not a trading day, the first trading day immediately following such date).
- [F2]Represents the weighted average price of the shares sold on May 4, 2026. The prices of the shares sold pursuant to the transactions ranged from $44.19 to $45.19 per share. The Investment Trust, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- [F3]The shares of Common Stock reported herein are held directly by the Investment Trust , the general partner of which is wholly-owned by The Ian G.H. Ashken Living Trust (the "Ashken Trust"), of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
- [F4]Represents the weighted average price of the shares sold on May 4, 2026. The prices of the shares sold pursuant to the transactions ranged from $45.20 to $45.74 per share. The Investment Trust, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- [F5]The Investment Trust contributed shares of Common Stock to an exchange fund in exchange for shares in the fund. The Common Stock was valued at $44.71 per share for the purpose of determining the number of shares of the exchange fund issuable to the Investment Trust.
- [F6]Represents the weighted average price of the shares sold on May 5, 2026. The prices of the shares sold pursuant to the transactions ranged from $44.78 to $45.78 per share. The Nancy and Ian Ashken Investment Trust, LLLP, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- [F7]Represents the weighted average price of the shares sold on May 5, 2026. The prices of the shares sold pursuant to the transactions ranged from $45.79 to $46.00 per share. The Nancy and Ian Ashken Investment Trust, LLLP, upon request, will provide the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- [F8]The shares of Common Stock reported herein are held directly by the Nancy and Ian Ashken Investment Trust LLLP (formerly IGHA Holdings, LLLP), the general partner of which is wholly-owned by The Ian G.H. Ashken Living Trust (the "Ashken Trust"), of which Mr. Ashken is the trustee and beneficiary. Mr. Ashken disclaims beneficial ownership of any shares except to the extent of his pecuniary interest therein.
- [F9]Held jointly in an account by the Ashken Trust and the Nancy K. Ashken Living Trust.
Signature
/s/ Louis B. Lambert, Attorney-in-Fact|2026-05-06